Package 11822-0046-2

{"route": ["ORAL"], "spl_id": "a03e6b5b-fed4-dd64-160d-be1315e7cece", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1305603"], "spl_set_id": ["9fb0c938-d24b-2371-95db-6c82d9511d72"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Rite Aid Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (11822-0046-1)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "11822-0046-1", "marketing_start_date": "20220201"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (11822-0046-2)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "11822-0046-2", "marketing_start_date": "20220201"}], "brand_name": "Guaifenesin and Pseudoephedrine HCl", "product_id": "11822-0046_a03e6b5b-fed4-dd64-160d-be1315e7cece", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "11822-0046", "generic_name": "Guaifenesin and Pseudoephedrine HCL", "labeler_name": "Rite Aid Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Pseudoephedrine HCl", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "ANDA208369", "marketing_category": "ANDA", "marketing_start_date": "20220201", "listing_expiration_date": "20261231"}